| |
|
|
|
The Center for Professional Advancement, 90 Minute Accredited Online Training
March 5, 2009 at 11:00 a.m. - 12:30 p.m. (EST)
Who Should Attend
Professionals in the cosmetic and personal care or related industries that work and specialize in the following disciplines, as well as groups or companies that provide services in skin care to the following fields:
• Research and Development
• Regulatory Affairs
• Safety Assessment
• Product Development
• Formulations Development
Description
In the current environment of establishing regulations and environmental issues awareness, an effort is put together to offer guidance to individuals in the industry who are concerned with present approaches and future implications.
With the unique position of the cosmetic and personal care industry of animal testing ban and emergence of REACH, this course is designed to present key parties involved with market leads and sources for information.
The core of this 90-minute accredited training is focused on the understanding of current available methodologies to test for safety, their scope and limitations.
Module 1:
Definitions
• Skin irritation
• Skin corrosion
• Skin sensitization
Regulatory Status
• ECVAM- ESAC position
• Skin corrosion: Epiderm®, TER, Corrositex®, SkinEthicsv
• Skin irritation: general statement
ICCVAM Position
Module 2:
Skin Irritation
• Episkin®/ Epiderm® test
Skin Corrosion
• Epiderm®
• Episkin®
• Corrositex®
• TER
Module 3:
Skin Sensitization
• RIPT
• LLNA
• Approaches towards full replacement
Summary and Future Direction
Question and Answer Session
|
|
|
|
|
|
|
|
Organized by:
|
|
The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
Dr. Nava Dayan, Skin Care Research Expert
Dr. Nava Dayan earned her Ph.D. in Pharmaceutics from the Hebrew University in Jerusalem specializing in skin delivery. She is an Associate Adjunct Professor in the Ernest Mario School of Pharmacy at Rutgers University. During her 20 years of experience she has specialized in a variety of areas related to skin treatment including:- The research and understanding of the interaction between topically applied compounds and the skin.
- Findings in skin biochemistry and especially the upper layer of the skin- the stratum corneum
- Delivery of active compounds into and through the skin and the development of delivery systems to facilitate transport, improve bio-availability and reduce toxicity
- Design and development of topically applied formulations
- Design of clinical studies to substantiate market claims and to assure safety
- Academic teaching and lecturing
- Industrial experience in both development of active compounds, delivery systems and finished formulations
- Skin absorption studies in vivo and in vitro for safety/ efficacy assessment
- In vitro methodologies for safety assessment of topically applied compounds
Dr. Dayan has received numerous awards of excellence for various papers she has authored. She is the author and coauthor of more then 80 publications. Dr. Dayan is a member of the Dermatopharmaceutics Focus Group, and the Abstract Review Committee for the American Association of Pharmaceutical Scientists (AAPS), and the Consumer Products Group of the International Controlled Release Society (CRS). She is also a member of the US Society of Cosmetic Chemists, and the chair of the Annual Cosmeceuticals Summit Symposium. Dr. Dayan teaches at Rutgers University and is the Director of several public and online courses at the Center for Professional Advancement.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
salbers@cfpa.com
|
|
|
|
|
|
|
|
|